From nature to cancer therapy: Evaluating the Streptomyces clavuligerus secondary metabolites for potential protein kinase inhibitors.

Saini, Ravi; Kumari, Sonali; Singh, Amit; Mishra, Abha

Saini, Ravi; Kumari, Sonali; Singh, Amit; Mishra, Abha.

Afiliação

Saini R; Biomolecular Laboratory, School of Biochemical Engineering, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, India.
Kumari S; Biomolecular Laboratory, School of Biochemical Engineering, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, India.
Singh A; Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Mishra A; Biomolecular Laboratory, School of Biochemical Engineering, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, India.

J Cell Biochem ; 125(1): 59-78, 2024 01.

Article em En | MEDLINE | ID: mdl-38047468

Assuntos

Neoplasias; Inibidores de Proteínas Quinases; Streptomyces; Masculino; Humanos; Inibidores de Proteínas Quinases/farmacologia; Simulação de Acoplamento Molecular; Fator A de Crescimento do Endotélio Vascular; Epirubicina; Células MCF-7

Palavras-chave

Streptomyces 85E; Streptomyces clavuligerus; batch fermentation; epirubicin; receptor tyrosine kinases inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Streptomyces / Inibidores de Proteínas Quinases / Neoplasias Limite: Humans / Male Idioma: En Revista: J Cell Biochem Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google